Skip to main content
Top
Published in: International Journal of Clinical Oncology 4/2009

01-08-2009 | Original Article

Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial

Authors: Mamoru Tsukuda, Junichi Ishitoya, Yasukazu Mikami, Hideki Matsuda, Hideaki Katori, Choichi Horiuchi, Machiko Kimura, Takahide Taguchi, Takafumi Yoshida, Junichi Nagao, Yasunori Sakuma, Gabor Toth

Published in: International Journal of Clinical Oncology | Issue 4/2009

Login to get access
Metadata
Title
Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial
Authors
Mamoru Tsukuda
Junichi Ishitoya
Yasukazu Mikami
Hideki Matsuda
Hideaki Katori
Choichi Horiuchi
Machiko Kimura
Takahide Taguchi
Takafumi Yoshida
Junichi Nagao
Yasunori Sakuma
Gabor Toth
Publication date
01-08-2009
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 4/2009
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-008-0874-z

Other articles of this Issue 4/2009

International Journal of Clinical Oncology 4/2009 Go to the issue

Introduction to Review Articles

Treatment of metastatic brain tumors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine